Study Stopped
On reviewing of new data
Comparative Study to Examine Whether Echocardiography Performed During Cardiac Resynchronization Therapy Device Implantation Can Improve the Response Rate
E-OPT
OPTimization of Left-Ventricular Lead Implantation by Echocardiography- E-OPT Study
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Empirical implantation of the left ventricular lead is the prevailing practice in cardiac resynchronization therapy device implantation. The response rate to the therapy has been uniformly 70% only despite various methods to screen patients before device implantation. This study tested the hypothesis that echocardiography to assess acute resynchronization of the left ventricle during device implantation may improve the response rate to the therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2009
CompletedFirst Posted
Study publicly available on registry
November 16, 2009
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedSeptember 4, 2015
September 1, 2015
Same day
November 13, 2009
September 3, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical response (Improvement in functional class status by at least one NYHA Class or ≥10% increase in 6-minute hall walk distance) to CRT
6 months after device implantation
Secondary Outcomes (3)
Echocardiographic response of ≥15% reduction in LVESV
6 months after device implantation
Echocardiographic response of absolute increase of ≥5% in LVEF
6 months after device implantation
Biochemical response with reduction of BNP level≥15%
6 months after device implantation
Study Arms (2)
Empirical
ACTIVE COMPARATOREmpirical implantation of the left ventricular lead during cardiac resynchronization therapy device implantation
Echocardiography-guided approach
EXPERIMENTALEchocardiography-guided implantation of the left ventricular lead during cardiac resynchronization therapy device implantation
Interventions
Empirical implantation of the left ventricular lead during cardiac resynchronization therapy device implantation
Echocardiography-guided implantation of the left ventricular lead during cardiac resynchronization therapy device implantation
Eligibility Criteria
You may qualify if:
- Patients with SR or AF, indicated for CRT procedures (NYHA Class III or ambulatory Class IV despite optimal medical therapy, QRSd≥120ms and LVEF≤35%)
- Patients with ischaemic or non-ischaemic cardiomyopathy can be recruited
You may not qualify if:
- Patients already implanted with an implantable cardiac device, undergoing device upgrade or generator replacement
- Patients who aged less than 18 or over 80.
- Patients who are pregnant.
- Patients who cannot give informed consent.
- Patients who are judged to have severe mental impairment and cannot report symptoms of heart failure during follow-up.
- Patients who have comorbid congenital heart disease.
- Patients who have severe valvular heart disease, apart from severe mitral regurgitation.
- Patients who have unstable angina or who are within 1 month of myocardial infarction.
- Patients who have severe lung disease and accurate clinical assessment for heart failure symptoms cannot be performed.
- Patients who have poor echocardiographic windows precluding reliable echocardiographic examination during baseline assessment, CRT procedures or follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Princess Margaret Hospital, Hong Konglead
- Medtroniccollaborator
Study Sites (1)
Princess Margaret Hospital
Hong Kong, 852, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ngai Yin Chan, MBBS
Princess Margaret Hospital, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
November 13, 2009
First Posted
November 16, 2009
Study Start
June 1, 2015
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
September 4, 2015
Record last verified: 2015-09